BIOFORCE NANOSCIENCES HOLDINGS, INC. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Bioforce Nanosciences Holdings, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q3 2024.
  • Bioforce Nanosciences Holdings, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 29.3M shares, unchanged year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 29.3M 0 0% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 29.3M 0 0% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 29.3M 0 0% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 29.3M 0 0% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 29.3M 0 0% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 29.3M 0 0% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 29.3M 0 0% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 29.3M 0 0% Dec 31, 2022 10-K 2024-04-01
Q3 2022 29.3M 0 0% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 29.3M 0 0% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 29.3M 0 0% Mar 31, 2022 10-Q/A 2022-05-05
Q4 2021 29.3M 0 0% Dec 31, 2021 10-K 2023-03-28
Q3 2021 29.3M +14M +91.7% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 29.3M +14M +91.7% Jun 30, 2021 10-Q/A 2021-07-30
Q1 2021 29.3M +14M +91.7% Mar 31, 2021 10-Q 2021-04-27
Q4 2020 29.3M +14M +91.7% Dec 31, 2020 10-K 2022-02-11
Q3 2020 15.3M -61.1M -80% Sep 30, 2020 10-Q 2020-10-23
Q2 2020 15.3M -61M -80% Jun 30, 2020 10-Q 2020-07-22
Q1 2020 15.3M -61M -80% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 15.3M +8.87K +0.06% Dec 31, 2019 10-K 2021-02-16
Q3 2019 76.3M +25.6K +0.03% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 76.3M Jun 30, 2019 10-Q 2019-07-22
Q1 2019 76.3M Mar 31, 2019 10-Q 2019-04-30
Q4 2018 15.3M -61M -80% Dec 31, 2018 10-K/A 2020-03-09
Q3 2018 76.3M Sep 30, 2018 10-Q 2018-10-24
Q4 2017 76.3M Dec 31, 2017 10-K 2019-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.